HIGHLIGHTS
- who: Emile B. Veenstra from the University of Groningen have published the Article: Comparison of [, in the Journal: (JOURNAL)
- what: The aim of this study was to explore differences in tumour detection of both tracers and their relevance for selecting patients for PRRT.
SUMMARY
Patients and study design Lutetium treatment A maximum of four cycles of 7.4 GBq of_[177Lu]DOTA-TATE was intravenously infused over a timeframe of 30 min. Patients received infusions every 6 to 12 weeks (goal cumulative activity: 29.6 GBq). Patients Eight patients (5 male . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.